EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H22N4O |
| Net Charge | 0 |
| Average Mass | 298.390 |
| Monoisotopic Mass | 298.17936 |
| SMILES | CN(C)c1ccc(CC(=O)/N=c2/cc(C3CCC3)nn2)cc1 |
| InChI | InChI=1S/C17H22N4O/c1-21(2)14-8-6-12(7-9-14)10-17(22)18-16-11-15(19-20-16)13-4-3-5-13/h6-9,11,13H,3-5,10H2,1-2H3,(H2,18,19,20,22) |
| InChIKey | PGTNTDKBRSQDNM-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| CP681301 (CHEBI:232980) has role antineoplastic agent (CHEBI:35610) |
| CP681301 (CHEBI:232980) has role EC 2.7.11.22 (cyclin-dependent kinase) inhibitor (CHEBI:82665) |
| CP681301 (CHEBI:232980) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-[4-(dimethylamino)phenyl]acetamide |
| Citations |
|---|